March 7, 2017 / 2:42 PM / 5 months ago

BRIEF-Redhill Biopharma says U.S. District court granted Concordia unit treble damages

March 7 (Reuters) - Redhill Biopharma Ltd

* Redhill Biopharma - U.S. District court granted Concordia unit treble damages related to false claims made by Method Pharmaceuticals, LLC, principal owner

* Redhill Biopharma - Redhill expects to initiate promotion of Donnatal in Q2 of 2017

* Redhill Biopharma - court awarded Concordia treble damages of $2.2 million, an increase from original damages award of $733,000

* Redhill Biopharma - in Jan, co announced co-promotion agreement with unit of Concordia, granting co certain promotional rights in U.S. for Donnatal Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below